scholarly journals Assessment of epidemiological determinants of obesity among nursing staff in a tertiary healthcare center in northern Maharashtra: a cross sectional study

2017 ◽  
Vol 4 (7) ◽  
pp. 2506
Author(s):  
Anant N. Borde ◽  
Amol D. Kinge ◽  
Mukesh Bawa ◽  
Vikrant Pagar ◽  
Parth Vyas
Keyword(s):  
Nursing Staff ◽  
Health Behaviours ◽  
Cross Sectional Study ◽  
Morbidly Obese ◽  
Sectional Study ◽  
Cross Sectional ◽  
Healthcare Center ◽  
Total Prevalence ◽  
Tertiary Healthcare ◽  
Doctors And Nurses

Background: Obesity is now-a-days is considered as diseases. India is currently experiencing rapid epidemiological transition. Doctors and nurses play a vital role in the health and welfare of the people of a nation. Health of the doctors and nurses is of paramount importance and they are also known to have a sedentary lifestyle with high levels of stress and their own health behaviours are known to influence the public's confidence in advice offered. The purpose of this study is to find out prevalence of obesity among nurses and to assess its epidemiological determinants. Methods: It was a cross sectional study done among 200 nursing staff working in a tertiary healthcare center in Northern Maharashtra between September 2016 to March 2017. Data regarding socio-demographic profile, complete lifestyle history and general and systemic examinations were gathered and analysed using appropriate methods. Results: Out of total 200 nurses enrolled for the study 24% were males and 76% were females. All the participants were between the age group of 20-60 years. About 13% had altered sleep pattern while 15.5% women had menstrual irregularities. Overall prevalence’s of underweight, overweight, obesity and morbidly obese were found to be 8%, 27%, 13% and 3.5% respectively. Conclusions: Based on findings of the present study, we conclude that total prevalence of malnutrition (under nutrition plus over nutrition) found in this study was 51.5% and it was found to be associated with various modifiable risk factors. 

scholarly journals Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Shuichi Ito ◽  
Tomoko Torii ◽  
Akihiro Nakajima ◽  
Takeshi Iijima ◽  
Hiroshi Murano ◽  
...  
Keyword(s):  
Uric Acid ◽  
Health Insurance ◽  
Pediatric Population ◽  
Gouty Arthritis ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Insurance Claims ◽  
Cross Sectional ◽  
Total Prevalence ◽  
Health Insurance Claims

Abstract Background Although gout is rare in children, chronic sustained hyperuricemia can lead to monosodium urate deposits progressing to gout, just as in adults. This study assessed prevalence and characteristics of gout and asymptomatic hyperuricemia, and incidence of gouty arthritis in the pediatric population, using data from Japanese health insurance claims. The diagnosis and treatment of pediatric gout and hyperuricemia were analyzed, and specific characteristics of those patients were assessed. Since Japanese guidelines recommend treatment with uric acid lowering drugs for asymptomatic hyperuricemia as well as for gout, these data were also used to investigate the real-world use of uric acid lowering drugs in a pediatric population. Methods This cross-sectional study was based on a 2016–2017 Japanese health insurance claims database, one of the largest epidemiology claims databases available in Japan, which included 356,790 males and 339,487 females 0–18 years of age. Outcomes were measured for prevalence, patient characteristics, treatment with uric acid lowering drugs for gout and asymptomatic hyperuricemia, and prevalence and incidence of gouty arthritis. Because uric acid can be elevated by some forms of chemotherapy, data from patients under treatment for malignancies were excluded from consideration. Results Total prevalence of gout and asymptomatic hyperuricemia in 0–18 year-olds was 0.040% (276/696,277 patients), with gout prevalence at 0.007% (48/696,277) and asymptomatic hyperuricemia at 0.033% (228/696,277). Prevalence of gout and asymptomatic hyperuricemia was highest in adolescent males, at 0.135% (176/130,823). The most common comorbidities for gout and asymptomatic hyperuricemia were metabolic syndrome at 42.8% (118/276) and kidney disease at 34.8% (96/276). Of the patients diagnosed with gout or asymptomatic hyperuricemia, 35.1% (97/276) were treated with uric acid lowering drugs. Gouty arthritis developed in 43.8% (21/48) of gout patients during the study, at an incidence of 0.65 flares/person-year. Conclusions Even the pediatric population could be affected by asymptomatic hyperuricemia, gout, and gouty arthritis, and uric acid lowering drugs are being used in this population even though those drugs have not been approved for pediatric indications. Such off-label use may indicate a potential need for therapeutic agents in this population. Trial registration UMIN000036029.

scholarly journals Analysis of quality of life among asthmatic individuals with obesity and its relationship with pulmonary function: cross-sectional study

2017 ◽  
Vol 135 (4) ◽  
pp. 332-338 ◽  
Author(s):  
Letícia Baltieri ◽  
Luiz Claudio Martins ◽  
Everton Cazzo ◽  
Débora Aparecida Oliveira Modena ◽  
Renata Cristina Gobato ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Pulmonary Function ◽  
Cross Sectional Study ◽  
University Hospital ◽  
Morbidly Obese ◽  
Life Questionnaire ◽  
Sectional Study ◽  
Anthropometric Data ◽  
Cross Sectional

ABSTRACT CONTEXT AND OBJECTIVE: The combined effect of obesity and asthma may lead to significant impairment of quality of life (QOL). The aim here was to evaluate the prevalence of asthma among obese individuals, characterize the severity of impairment of quality of life and measure its relationship with pulmonary function. DESIGN AND SETTING: Observational cross-sectional study in public university hospital. METHODS: Morbidly obese individuals (body mass index > 40 kg/m2) seen in a bariatric surgery outpatient clinic and diagnosed with asthma, were included. Anthropometric data were collected, the Standardized Asthma Quality of Life Questionnaire (AQLQ(S)) was applied and spirometry was performed. The subjects were divided into two groups based on the median of the score in the questionnaire (worse < 4 and better > 4) and were compared regarding anthropometric data and pulmonary function. RESULTS: Among the 4791 individuals evaluated, 219 were asthmatic; the prevalence of asthma was 4.57%. Of these, 91 individuals were called to start multidisciplinary follow-up during the study period, of whom 82 answered the questionnaire. The median score in the AQLQ(S) was 3.96 points and, thus, the individuals were classified as having moderate impairment of their overall QOL. When divided according to better or worse QOL, there was a statistically difference in forced expiratory flow (FEF) 25-75%, with higher values in the better QOL group. CONCLUSION: The prevalence of asthma was 4.57% and QOL was impaired among the asthmatic obese individuals. The worst QOL domain related to environmental stimuli and the best QOL domain to limitations of the activities. Worse QOL was correlated with poorer values for FEF 25-75%.

Sign in / Sign up

Export Citation Format

Share Document